LEP Biomedical is developing a dissolvable implant that replaces weeks of self-administered eye drops after glaucoma surgery, aiming to fix the compliance problems that drive surgical failure rates as high as 40%.
The Cyclo G6 probe uses the company's MicroPulse technology, which prevents any tissue damage and connects to an external console.
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
When I first heard that Bullseye Dropper won the Innov8 for Health Start Up Showcase late last year, I thought, “Hmmm, interesting, but I’ll pass.” Then last month, my 5-year-old son got pink eye and needed eye drops. As I tried to stop his wiggling long enough to get a dose of the antibiotics into […]